|Post IPO Valuation|
|Venture Round, 12/2009 ||$3.3M|
|Venture Round, 11/2013 ||$126k|
|Partial Close, 2/2014 ||$2.03M|
iCo Therapeutics is a “Search and Development” company. By focusing efforts on development instead of research, iCo’s business model aims to acquire the rights to drugs that are either off-patent, currently approved or near commercialization and develop them by redosing or reformulating them for new or expanded labels. Subsequent development of these therapeutics may include drug delivery technologies-such as sustained release or biodegradable matrices to extend patent coverage.